The latest report by IMARC Group, titled, ” Protein Labeling Market: Industry Trends, Share, Size, Opportunity and Forecast 2022-2027″, offers a comprehensive analysis of the industry, which comprises insights on the Protein Labeling Market Share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global protein labeling market is expected to exhibit a CAGR of 9.4% during 2022-2027. Protein labeling is the process of using appropriate molecular labels to detect, purify and characterize proteins and their binding partners. It is performed by creating self-labeling tags and genetic fusions, which impart distinctive properties for selective protein visualization, manipulation, and entrapment within complex biochemical environments. The labels are attached covalently to the desired molecule, thus simplifying the processes of detection and purification. Moreover, the protein labeling process helps detect various proteins in tissues, cells, and biochemical assays as they are essential biomolecules vital for the functioning of living organisms.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/protein-labeling-market/requestsample
Global Protein Labeling Market Trends:
The global protein labeling market is driven by increasing advancement in proteomics research. For instance, research and development (R&D) activities have led to improvements in mass spectrometry workflows and miniaturization of biochips and protein microarray in proteomics, which have escalated the demand for protein labeling techniques. The market is also fueled by the rising adoption of modern molecular biology and bioengineering tools to enhance the knowledge of functional mechanisms on a subcellular scale. Consequently, it facilitates improvements in drug development, diagnosis, and therapy applications. Besides this, the extensive investments by the governments of various countries in the healthcare sector are propelling the market growth. Furthermore, the growing competition and the entry of small companies have resulted in the launch of new products, which can be customized according to the requirements of researchers.
Competitive Landscape with Key Players:
- Th Agilent Technologies Inc.
- Cytiva (Danaher Corporation)
- F. Hoffmann-La Roche Ltd. (Roche Holding AG)
- Jena Bioscience GmbH
- LGC Limited, LI-COR Inc.
- Merck KGaA
- New England Biolabs
- PerkinElmer Inc.
- Promega Corporation
- Thermo Fisher Scientific Inc.
Breakup by Labeling Method:
- In-Vitro Labeling
- In-Vivo Labeling
Breakup by Product:
Breakup by Application:
- Cell-based Assays
- Fluorescence Microscopy
- Mass Spectrometry
- Immunological Techniques
- Protein Microarray
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.